DK136037B - Analogifremgangsmåde til fremstilling af 1-(3-cyano-3,3-diphenylpropyl)-4-phenylpiperidin-4-carboxylsyrederivater eller syreadditionssalte deraf. - Google Patents

Analogifremgangsmåde til fremstilling af 1-(3-cyano-3,3-diphenylpropyl)-4-phenylpiperidin-4-carboxylsyrederivater eller syreadditionssalte deraf.

Info

Publication number
DK136037B
DK136037B DK607571AA DK607571A DK136037B DK 136037 B DK136037 B DK 136037B DK 607571A A DK607571A A DK 607571AA DK 607571 A DK607571 A DK 607571A DK 136037 B DK136037 B DK 136037B
Authority
DK
Denmark
Prior art keywords
diphenylpropyl
phenylpiperidine
cyano
preparation
addition salts
Prior art date
Application number
DK607571AA
Other languages
English (en)
Other versions
DK136037C (da
Inventor
Eunice Marie Kreider
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB5968670A external-priority patent/GB1356117A/en
Application filed by Searle & Co filed Critical Searle & Co
Publication of DK136037B publication Critical patent/DK136037B/da
Application granted granted Critical
Publication of DK136037C publication Critical patent/DK136037C/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/451Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C07D211/64Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having an aryl radical as the second substituent in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK607571AA 1970-12-16 1971-12-13 Analogifremgangsmåde til fremstilling af 1-(3-cyano-3,3-diphenylpropyl)-4-phenylpiperidin-4-carboxylsyrederivater eller syreadditionssalte deraf. DK136037B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5968670A GB1356117A (en) 1970-12-16 1970-12-16 1-3-cyano-3,3-diphenylpropyl-4-phenylpiperidine-4-carboxylic acid derivatives

Publications (2)

Publication Number Publication Date
DK136037B true DK136037B (da) 1977-08-01
DK136037C DK136037C (da) 1978-01-02

Family

ID=10484227

Family Applications (2)

Application Number Title Priority Date Filing Date
DK607571AA DK136037B (da) 1970-12-16 1971-12-13 Analogifremgangsmåde til fremstilling af 1-(3-cyano-3,3-diphenylpropyl)-4-phenylpiperidin-4-carboxylsyrederivater eller syreadditionssalte deraf.
DK607671AA DK130966B (da) 1970-12-16 1971-12-13 Analogifremgangsmåde til fremstilling af 1-(3-cyano-3,3-diphenylpropyl)-4-phenylpiperidin-4-carboxylsyre-derivater eller syreadditionssalte deraf.

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK607671AA DK130966B (da) 1970-12-16 1971-12-13 Analogifremgangsmåde til fremstilling af 1-(3-cyano-3,3-diphenylpropyl)-4-phenylpiperidin-4-carboxylsyre-derivater eller syreadditionssalte deraf.

Country Status (9)

Country Link
JP (1) JPS5542996B1 (da)
CA (1) CA918157A (da)
CY (1) CY925A (da)
DK (2) DK136037B (da)
ES (4) ES397912A1 (da)
IE (2) IE35889B1 (da)
SE (2) SE370542B (da)
YU (2) YU34990B (da)
ZA (2) ZA718379B (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6115962U (ja) * 1984-06-30 1986-01-30 儀介 野沢 豚用飼槽

Also Published As

Publication number Publication date
ES397912A1 (es) 1975-04-16
YU34990B (en) 1980-06-30
IE35889B1 (en) 1976-06-23
IE35890B1 (en) 1976-06-23
IE35890L (en) 1972-06-16
DK130966B (da) 1975-05-12
SE370542B (da) 1974-10-21
IE35889L (en) 1972-06-16
ES400479A1 (es) 1975-01-16
CY925A (en) 1977-12-23
CA918157A (en) 1973-01-02
ES397911A1 (es) 1975-04-16
DK130966C (da) 1975-10-06
SE370543B (da) 1974-10-21
YU34991B (en) 1980-06-30
YU248678A (en) 1979-12-31
ZA718380B (en) 1973-02-28
ZA718379B (en) 1973-02-28
JPS5542996B1 (da) 1980-11-04
DK136037C (da) 1978-01-02
ES400478A1 (es) 1975-01-01
YU248778A (en) 1979-12-31

Similar Documents

Publication Publication Date Title
DK129446B (da) Analogifremgangsmåde til fremstilling af fenoxyhydroxypropylaminer eller syreadditionssalte heraf.
DK124547B (da) Analogifremgangsmåde til fremstilling af (3-amino-2-hydroxy-propyloxy)-thiochromanderivater eller syreadditionssalte deraf.
DK123824C (da) Analogifremgangsmåde til fremstilling af derivater af N-(3,4,5-trimethoxy-cinnamoyl)-piperazin eller syreadditionssalte deraf.
DK131858B (da) Analogifremgangsmåde til fremstilling af 4-amino-6-arylpyrimidin-forbindelser eller syreadditionssalte deraf.
DK137382B (da) Analogifremgangsmåde til fremstilling af 2,2-diaryl-4-(4'-aryl-4'-hydroxy-piperidin)butyramider eller syreadditionssalte deraf.
DK132275B (da) Analogifremgangsmåde til fremstilling af antiviralt aktive 2,7-bis-(tert.aminoalkanoyl)-xanthener eller -xanthen-9-oner eller syreadditionssalte deraf.
DK124748B (da) Analogifremgangsmåde til fremstilling af N-(fenylalkyl)-acylamider eller syreadditionssalte deraf.
DK127116B (da) Analogifremgangsmåde til fremstilling af imidazolidinonderivater eller syreadditionssalte deraf.
DK139098B (da) Analogifremgangsmåde til fremstilling af imidazoliner eller ikke-toxiske, farmaceutisk anvendelige syreadditionssalte deraf.
DK137044B (da) Analogifremgangsmåde til fremstilling af 4,4-diphenylhexahydroazepinderivater eller syreadditionssalte deraf.
DK128494C (da) Fremgangsmåde til fremstilling af amidino-urinstoffer eller syreadditionssalte heraf.
DK140259B (da) Analogifremgangsmåde til fremstilling af 1-(L-(-)-omega-amino-alfa-hydroxyalkanoyl)-kanamyciner eller syreadditionssalte deraf.
DK129164B (da) Analogifremgangsmåde til fremstilling af 3-alkyl-5-aryloxymethylisoxazoler eller syreadditionssalte deraf.
DK130966B (da) Analogifremgangsmåde til fremstilling af 1-(3-cyano-3,3-diphenylpropyl)-4-phenylpiperidin-4-carboxylsyre-derivater eller syreadditionssalte deraf.
DK130288B (da) Analogifremgangsmåde til fremstilling af alkanolaminderivater eller syreadditionssalte deraf.
DK127117B (da) Analogifremgangsmåde til fremstilling af imidazolidinonderivater eller syreadditionssalte deraf.
DK137834B (da) Analogifremgangsmåde til fremstilling af triazolobenzodiazepinderivater eller syreadditionssalte deraf.
DK129124B (da) Analogifremgangsmåde til fremstilling af 1-(3-cyano-3,3-diphenylpropyl)-4-phenylisonipecotinsyre eller syreadditionssalte deraf.
DK112952B (da) Fremgangsmåde til fremstilling af N-(4-alkylaminoalkoxy-benzyl)-3,4-dialkoxy-benzamider eller syreadditionssalte deraf.
DK131570B (da) Analogifremgangsmåde til fremstilling af thienylalkanderivater eller syreadditionssalte deraf.
DK129839B (da) Analogifremgangsmåde til fremstilling af N-vinylquinoloner eller syreadditionssalte deraf.
DK123293B (da) Analogifremgangsmåde til fremstilling af N-substitueret 1-(2-hydroxy-3-aminopropoxy)-9-fluorenon eller syreadditionssalte heraf.
DK136064B (da) Fremgangsmåde til fremstilling af 3,4-dihydroisoquinolinderivater eller syreadditionssalte eller kvaternære salte deraf.
DK133874B (da) Analogifremgangsmåde til fremstilling af 4beta-methoxy-4alfa-phenyl-1-phenethyl-3alfa,5alfa-propano-piperidin eller syreadditionssalte heraf.
DK126033B (da) Analogifremgangsmåde til fremstilling af N<1>-tyrosyl-N<2>-(2,3,4-trihydroxybenzyl)-hydrazin eller syreadditionssalte deraf.